VERU INC. Nontrade Receivables, Current
VERU INC. (VERU) had Nontrade Receivables, Current of $5.00 million as of 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:NontradeReceivablesCurrent · last filed 2021-08-12
- 2021-06-30: Nontrade Receivables, Current $5.00M.
- 2021-03-31: Nontrade Receivables, Current $2.50M.
- 2020-12-31: Nontrade Receivables, Current $2.50M.
| Period end | Nontrade Receivables, Current |
|---|---|
| 2021-06-30 | $5.00M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.50M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $2.50M 10-Q · filed 2021-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |